Close Menu

News - Events

Imexpharm Accompanies the VILA 2025 National Scientific Conference on Pulmonary Diseases
Imexpharm Accompanies the VILA 2025 National Scientific Conference on Pulmonary Diseases
By accompanying the VILA 2025 National Scientific Conference on Pulmonary Diseases, held in Can Tho in November 2025 and attended by more than 1,000 respiratory specialists, Imexpharm continues to reaffirm its long-term commitment to respiratory health for the community.
9M2025 - Imexpharm Facts & Figures
9M2025 - Imexpharm Facts & Figures
Imexpharm 3Q2025 Earnings Call Invitation

Imexpharm 3Q2025 Earnings Call Invitation

Imexpharm honored for the 6th consecutive time in Vietnam’s 50 Best Performing Companies

Imexpharm honored for the 6th consecutive time in Vietnam’s 50 Best Performing Companies

Imexpharm accelerates HR Digital transformation with FPT.iHRP

Imexpharm accelerates HR Digital transformation with FPT.iHRP

1H2025 - Imexpharm Facts & Figures

1H2025 - Imexpharm Facts & Figures

CSA 2025 honors Imexpharm for sustainable journey toward community and environment

CSA 2025 honors Imexpharm for sustainable journey toward community and environment

Imexpharm 1H2025 Earnings Call Invitation

Imexpharm 1H2025 Earnings Call Invitation

1Q2025 - Imexpharm Facts & Figures

1Q2025 - Imexpharm Facts & Figures

Imexpharm 1Q2025 Earnings Call Invitation

Imexpharm 1Q2025 Earnings Call Invitation

Imexpharm targets VND2,981 billion in total revenue at 2025, up 18,6%

Imexpharm targets VND2,981 billion in total revenue at 2025, up 18,6%

Imexpharm Empowering Vietnam’s Medical Innovation

Imexpharm Empowering Vietnam’s Medical Innovation

As a pioneer in the production of high-quality pharmaceuticals, Imexpharm consistently accompanies the medical community through scientific and professional initiatives, affirming its role as a leading pharmaceutical company dedicated to public health.